Trials / Completed
CompletedNCT03085108
A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment
Validation and Mapping of the Suicide Ideation and Behavior Assessment Tool in Subjects at Various Levels of Risk for Suicide
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Janssen Scientific Affairs, LLC · Industry
- Sex
- All
- Age
- 12 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No Intervention |
Timeline
- Start date
- 2017-03-31
- Primary completion
- 2017-11-14
- Completion
- 2017-11-14
- First posted
- 2017-03-21
- Last updated
- 2025-02-03
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03085108. Inclusion in this directory is not an endorsement.